COSM - Company ID 0001474167
Cosmos Health Inc. trades as COSM. In its fiscal 2025 annual report the company posted revenue of $65.27M, up 19.9% from the prior year and net income of -$19.14M. This page tracks Cosmos Health Inc. through 600 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
With latest filings
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 9 fiscal years Cosmos Health Inc.'s revenue grew from $6.76M to $65.27M, a compound annual growth rate of 28.7%. Net profit margin compressed from -8.9% to -29.3% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| PRE 14A | - | 2026-05-22 |
| Major company event | 8-K | 2026-05-22 |
| Quarterly report | 10-Q | 2026-05-20 |
| NT 10-Q | - | 2026-05-15 |
| RW | - | 2026-05-11 |
| SCHEDULE 13G/A | - | 2026-04-24 |
| S-3/A | - | 2026-04-24 |
| Major company event | 8-K | 2026-04-16 |
The largest companies sharing Cosmos Health Inc.'s SEC industry classification (wholesale-drugs, proprietaries & druggists' sundries).
Cosmos Health Inc. reported revenue of $65.27M for fiscal year 2025, an increase of 19.9% year over year.
In its latest fiscal year Cosmos Health Inc. reported a net loss of $19.14M.